[Does selenium reduce the cancer risk in man?].

Dtsch Med Wochenschr

Published: April 1989

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2008-1066636DOI Listing

Publication Analysis

Top Keywords

[does selenium
4
selenium reduce
4
reduce cancer
4
cancer risk
4
risk man?]
4
[does
1
reduce
1
cancer
1
risk
1
man?]
1

Similar Publications

Selenium is an essential element with various industrial and medical applications, hence the current considerable attention towards the genesis and utilization of SeNPs. SeNPs and other nanoparticles could be achieved via physical and chemical methods, but these methods would not only require expensive equipment and specific reagents but are also not always environment friendly. Biogenesis of SeNPs could therefore be considered as a less troublesome alternative, which opens an excellent window to the selenium and nanoparticles' world.

View Article and Find Full Text PDF

Discovery of Selenium-Containing Derivatives as Potent and Orally Bioavailable GLP-1R Agonists.

J Med Chem

January 2025

Jiang Su Key Laboratory of Drug Design and Optimization and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

Glucagon-like peptide-1 receptor (GLP-1R) is a well-established target for the treatment of type 2 diabetes mellitus (T2DM) and obesity. The development of orally bioavailable and long-acting small-molecule GLP-1R agonists is a pursuit in both academia and industry. Herein, new selenium (Se)-containing compounds were designed using a Se-oxygen bioisostere strategy on the danuglipron scaffold.

View Article and Find Full Text PDF

Synthesis of [Fe[(μ-SeCH)NH](CN)(CO)] and Related Iron Selenoates.

Organometallics

January 2025

School of Chemical Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.

The dianion [Fe[(μ-SeCH)NH](CN)(CO)] ([]) is of interest for the preparation of the selenide analog of the active site of the [FeFe]-hydrogenases. The obvious route for its synthesis by cyanation of Fe[(μ-SeCH)NH](CO) () fails for reasons that this paper explains and resolves. We show that CN cleaves Se-C bonds in .

View Article and Find Full Text PDF

The objective of the present study was to assess serum and cancerous tissue biometal levels in colorectal cancer (CRC) patients, and its relation to disease severity. A total of 90 CRC patients and 97 controls were involved in the present study. The level of biometals in blood serum and colon tissues (only in CRC cases) was evaluated by inductively-coupled plasma mass-spectrometry.

View Article and Find Full Text PDF

Iron metabolism in a mouse model of hepatocellular carcinoma.

Sci Rep

January 2025

Institute of Comparative Molecular Endocrinology, Ulm University, 89081, Ulm, Germany.

Hepatocellular carcinoma (HCC) remains the most prevalent type of primary liver cancer worldwide. p53 is one of the most frequently mutated tumor-suppressor genes in HCC and its deficiency in hepatocytes triggers tumor formation in mice. To investigate iron metabolism during liver carcinogenesis, we employed a model of chronic carbon tetrachloride injections in liver-specific p53-deficient mice to induce liver fibrosis, cirrhosis and subsequent carcinogenesis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!